FdaApplication
ANDA 212300
Identifiers
- fda_app_no: ANDA212300
Properties
| Property | Value |
|---|---|
| applicant_name | HIKMA PHARMS |
| application_type | ANDA |
| approval_date | 2022-06-10 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| NALOXONE HYDROCHLORIDE | NALOXONE HYDROCHLORIDE | 1MG/ML | INJECTABLE;INJECTION |
| NALOXONE HYDROCHLORIDE | NALOXONE HYDROCHLORIDE | 0.4MG/ML | INJECTABLE;INJECTION |
2 products